Stock listing

Lang & Schwarz:A2JGN2 Gabather AB Aktie

German listing (Lang & Schwarz) of Gabather AB · home listing Stockholm:GABA

Follow Gabather AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:GABA

0.015 SEK -0.003 (-16.3%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:GABA

Past year -48.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
0.012 – 0.019 SEKNov 20, 2026
Volume
8.50M sharesNov 20, 2026
Market cap
9.40M SEKAt the close on Nov 20, 2026 · price × 610.5M shares outstanding
52-week range
0.012 – 0.100 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
62,360 SEKMedian day 1.80M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Gabather AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:GABA · Home0.015 SEK-0.003 (-16.3%)8,496,2020.0190.0190.0120.018Close on Nov 20, 2026
Frankfurt:5J2€0.0050 EUR+0.0030 (+150.0%)——€0.0050—€0.0020Close on Oct 27, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:GABA · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.015-0.003-16.3%0.0190.0190.0128,496,202
0.018+0.000+2.2%0.0180.0180.017163,884
0.018-0.002-8.2%0.0190.0190.0171,097,209
0.020+0.001+7.7%0.0160.0200.0162,992,208
0.018-0.001-3.2%0.0190.0190.0161,834,794
0.019-0.001-6.0%0.0200.0200.0171,808,693
0.020-0.001-2.9%0.0210.0210.018502,928
0.021+0.001+7.3%0.0180.0210.0174,181,673
0.0190.000-1.0%0.0190.0190.0181,348,052
0.019-0.001-3.0%0.0200.0200.0181,024,033
0.0200.0000.0%0.0200.0200.0182,278,875
0.0200.0000.0%0.0200.0210.0191,583,088
0.020+0.002+9.9%0.0200.0250.01911,584,259
0.018-0.001-7.1%0.0180.0190.018813,169
0.0200.000-1.0%0.0190.0200.0183,931,480
0.020-0.001-2.9%0.0200.0210.020467,271
0.020-0.001-2.9%0.0200.0200.0193,020,977
0.021-0.002-7.1%0.0230.0230.0193,931,027
0.023+0.001+2.7%0.0210.0230.0183,778,040
0.022-0.001-2.7%0.0240.0240.0213,153,995
0.023+0.002+8.7%0.0210.0260.0215,582,793
0.021-0.001-5.5%0.0220.0220.0201,972,941
0.022-0.002-6.8%0.0240.0240.0212,922,652
0.0240.000-1.7%0.0240.0240.0222,593,778
0.024-0.002-7.7%0.0250.0260.0204,605,189
0.026+0.001+4.0%0.0240.0280.0241,443,470
0.025+0.001+4.2%0.0240.0250.0231,331,031
0.0240.000-1.6%0.0230.0240.023309,655
0.0240.000-0.8%0.0230.0250.023325,041
0.025-0.001-3.9%0.0260.0260.023618,117
0.026+0.001+2.4%0.0260.0260.0231,795,698
0.025-0.001-3.1%0.0250.0260.0251,512,155
0.0260.000-1.5%0.0260.0280.0254,692,816
0.026-0.002-6.4%0.0260.0280.026578,082
0.028+0.001+5.3%0.0270.0300.0253,298,395
0.027+0.001+3.9%0.0260.0270.025967,393
0.026-0.002-5.9%0.0270.0270.0251,840,994
0.027+0.002+7.9%0.0270.0280.0251,317,751
0.025-0.003-10.6%0.0250.0340.0255,788,710
0.0280.000-0.7%0.0260.0280.0241,149,413
0.028+0.000+0.7%0.0260.0280.026351,605
0.0280.000-1.4%0.0260.0290.026692,727
0.029+0.002+6.7%0.0270.0290.0262,474,363
0.027+0.000+0.8%0.0270.0270.0251,332,452
0.027-0.001-2.9%0.0280.0280.0251,045,106
0.027-0.003-8.7%0.0300.0300.0262,835,540
0.0300.000-0.7%0.0300.0300.028596,598
0.030+0.000+1.3%0.0300.0300.029316,407
0.0300.000-0.7%0.0300.0300.0271,837,604
0.030+0.001+3.4%0.0310.0310.029733,916
0.029-0.002-6.5%0.0310.0310.0282,831,959
0.0310.0000.0%0.0310.0320.028873,483
0.031-0.001-2.5%0.0320.0320.0301,182,116
0.032+0.001+4.6%0.0300.0320.030744,962
0.030+0.001+4.8%0.0290.0300.029691,200
0.029-0.007-19.4%0.0380.0380.0288,699,790
0.036+0.002+5.3%0.0320.0390.02911,127,995
0.034+0.000+1.2%0.0340.0340.0323,119,266
0.034-0.001-2.9%0.0350.0350.0315,594,904
0.035+0.004+13.0%0.0310.0360.0313,176,265
0.0310.0000.0%0.0320.0320.031111,677
0.031-0.001-3.7%0.0320.0320.0311,906,007
0.032+0.000+1.3%0.0310.0320.030343,710
0.032-0.001-3.7%0.0330.0330.0302,781,064

Splits

1 split · OMXSTO:GABA · every price before a split is adjusted for it

DayRatioWhat
1-for-4Consolidation
Ticker
Lang & Schwarz:A2JGN2
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

Latest news

All Gabather AB news

Gabather AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in all · newest Jan 13, 2025 · oldest 2025
Decks
2 decks · latest Dec 18, 2023

Where Gabather AB is listed

ListingExchangeCountryCurrency
Stockholm:GABA · Home listingStockholmSwedenSEK
gettex:5J2gettexGermanyEUR
LS Exchange:A2JGN2LS ExchangeGermanyEUR
Frankfurt:5J2FrankfurtGermanyEUR
Lang & Schwarz:A2JGN2 · This pageLang & SchwarzGermanyEUR
Munich:5J2MunichGermanyEUR

Valuation

Price/book 6.4× against a median of 0.3×: the highest of 11 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
5.72M SEK
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
6.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Gabather AB · OMXSTO:GABAUS$921,605US$560,377n/an/an/a6.4×n/a0.0×n/a
Artelo Biosciences, Inc. · NASDAQ:ARTLUS$1.30MUS$1.34Mn/an/an/a0.2×n/a0.0×1.36
International Stem Cell Corporation · OTC:ISCOUS$1.28M−US$18.76M0.1×−2.0×n/a0.1×222.6%0.0×-0.52
SureNano Science Ltd · CSE:SUREUS$1.17MUS$672,415n/an/an/a0.3×n/a0.0×0.25
Valion Bio, Inc. · NASDAQ:VBIOUS$1.04MUS$16.34Mn/a42.8×n/a0.2×n/a4.1×1.11
GeoVax Labs, Inc. · NASDAQ:GOVXUS$985,460−US$915,033n/an/an/a0.9×n/a0.2×1.47
Biodexa Pharmaceuticals plc · NASDAQ:BDRXUS$982,950−US$3.22Mn/an/an/a0.1×n/a0.0×1.01
ExpreS2ion Biotech Holding AB · OMXSTO:EXPRS2US$794,437−US$2.43Mn/a−6.5×n/a0.2×−935.9%0.0×n/a
Silexion Therapeutics Corp · NASDAQ:SLXNUS$790,001−US$3.60Mn/an/an/a0.3×n/a0.1×2.77
Oragenics Inc. · AMEX:OGENUS$708,377−US$1.12Mn/an/an/a0.7×n/a0.4×1.47
Protagenic Therapeutics, Inc. · OTC:PTIXUS$687,879US$610,9700.1×n/an/a0.6×n/a0.0×1.21
Median of the othersUS$984,205−US$1.02M0.1×−2.0×0.3×−356.6%0.0×1.21

Team and board

Officers

OfficerRole
Michael-Robin WittCEO & CSO
Christine RyanCOO

Board

DirectorRole
Bert JunnoBoard member
Michael-Robin WittCEO & CSO
Theresa Comiskey OlsenBoard member

Events

QuarterResultsShare move
Q2 2026Aug 27, 2026−1.7%
Q1 2026May 28, 2026−6.5%
Q4 2025Feb 26, 2026+33.3%
Q3 2025Nov 27, 2025+9.3%
Q2 2025Aug 28, 2025−13.7%
Q1 2025May 28, 2025−16.3%
Q1 2024Jun 28, 2024 · After close+1.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2023)Investor deck25 slidesDec 18, 2023
Corporate Update (June 2023)Corporate update19 slidesJun 28, 2023

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000-23.0K037045.9K3.01M476.3K
Cost of revenue84.2K84.2K65.3K59.1K
Gross profit-84.2K-84.2K-65.3K-59.1K
Selling, general and administrative2.09M3.80M4.14M4.52M12.4M8.03M6.64M13.1M6.97M3.96M
Operating income-4.53M-7.78M-9.47M-8.55M-17.0M-14.6M-14.3M-20.3M-9.94M-7.89M
Depreciation and amortization07.78M9.47M8.55M84.0K84.0K84.2K84.2K65.3K59.1K
EBITDA-4.53M000-16.9M-14.6M-14.2M-20.2M-9.87M-7.84M
Interest expense155.0K03.00K4.00K7.00K7.36K25.1K579216
Income before tax-4.65M-7.75M-9.44M-8.55M-17.0M-14.9M-14.3M-20.3M-9.94M-7.89M
Income tax9.47M-3.00K4.00K-115.0K7.36K25.1K579-320
Net income-4.65M-7.75M-9.44M-8.54M-17.0M-14.9M-14.3M-20.3M-9.94M-7.89M
Earnings per share, basic-0.02-0.37-0.65-0.63-1.27-1.12-2.22-3.94-2.69-2.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.14M878.0K1.11M6.27M14.8M30.9M44.9M16.6M36.7M27.9M
Receivables637.0K800.0K1.77M430.0K495.0K256.0K388.9K720.2K1.02M173.3K
Inventory-1.77K-430-495-256-388-720.2K-974.7K-27.9M
Current assets3.78M1.78M2.89M6.70M15.3M31.2M45.3M17.4M37.8M28.3M
Total assets3.83M1.83M7.36M6.75M15.4M32.2M46.1M18.2M48.2M34.7M
Accounts payable1.20M766.0K548.0K183.0K532.0K552.0K261.0K453.8K953.0K592.1K
Current liabilities4.69M6.01M6.88M3.31M4.43M3.31M2.48M2.29M2.42M1.56M
Total liabilities4.69M6.01M6.88M3.31M4.43M3.31M2.48M2.29M2.42M1.56M
Shareholders' equity-863.0K-4.17M486.0K3.44M11.0M27.9M43.6M15.9M45.8M33.2M
Shares outstanding192.2M20.7M14.5M13.6M13.4M13.4M6.44M5.16M3.70M3.65M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-7.22M-3.33M-11.6M-9.60M-16.1M-13.7M-13.7M-20.1M-9.68M-7.09M
Capital spending0000-345.0K-289.0K-73.9K-43.9K-4.03M-3.35M
Free cash flow-7.22M-3.33M-11.6M-9.60M-16.1M-14.0M-13.8M-20.1M-13.7M-10.4M
Cash from investing-289.0K-73.9K-43.9K-4.03M-3.35M
Cash from financing9.49M3.09M6.49M1.02M46.0K46.0K42.0M42.2M22.5M28.3M
Share buybacks9.49M3.09M6.49M1.02M46.0K042.0M022.5M28.3M
Change in cash2.27M-237.0K-5.16M-8.57M-16.1M-14.0M28.2M-20.1M8.81M17.9M

Open Financials

Cap table

Built by 6ix from Gabather AB’s releases

Common shares
610,491,290
Fully diluted
610,491,290

Fully diluted

LineShares
Common shares610,491,290

Share count over time

CountShares
Nov 22, 2026610,491,290

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bert JunnoBoard member · Since at least Nov 4, 2026
Christine RyanCOO · Since at least Nov 5, 2026
Michael-Robin WittCEO & CSO · Since at least Jan 13, 2025
Theresa Comiskey OlsenBoard member · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Gabather AB.